Hydroxychloroquine in the treatment of outpatients with mildly symptomatic COVID-19: a multi-center observational study

BACKGROUND: Hydroxychloroquine has not been associated with improved survival among hospitalized COVID-19 patients in the majority of observational studies and similarly was not identified as an effective prophylaxis following exposure in a prospective randomized trial. We aimed to explore the role...

Descripción completa

Detalles Bibliográficos
Autores principales: Ip, Andrew, Ahn, Jaeil, Zhou, Yizhao, Goy, Andre H., Hansen, Eric, Pecora, Andrew L., Sinclaire, Brittany A., Bednarz, Urszula, Marafelias, Michael, Sawczuk, Ihor S., Underwood, Joseph P., Walker, David M., Prasad, Rajiv, Sweeney, Robert L., Ponce, Marie G., La Capra, Samuel, Cunningham, Frank J., Calise, Arthur G., Pulver, Bradley L., Ruocco, Dominic, Mojares, Greggory E., Eagan, Michael P., Ziontz, Kristy L., Mastrokyriakos, Paul, Goldberg, Stuart L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7807228/
https://www.ncbi.nlm.nih.gov/pubmed/33446136
http://dx.doi.org/10.1186/s12879-021-05773-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7807228/
https://www.ncbi.nlm.nih.gov/pubmed/33446136
http://dx.doi.org/10.1186/s12879-021-05773-w

Ejemplares similares